Variant report

Variant	esv3461212
Chromosome Location	chr3:158350629-158352011
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

Extended variants
information (count: 63 )
Associated
traits (count: 59 )

Variant overlapped rSNPs/rCNVs (count:63 , 50 per page) page: 1 2

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs148457274	chr3:158350647-158350648	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
2	rs547746323	chr3:158350663-158350664	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs539717745	chr3:158350691-158350692	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs368204577	chr3:158350740-158350741	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs546264730	chr3:158350741-158350742	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs531262498	chr3:158350744-158350745	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
7	rs546108561	chr3:158350745-158350746	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs564402437	chr3:158350878-158350879	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs528672484	chr3:158350879-158350880	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs145105104	chr3:158350897-158350898	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs115460943	chr3:158350934-158350935	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs147593248	chr3:158350956-158350957	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs373080438	chr3:158350969-158350970	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
14	rs550585306	chr3:158350981-158350982	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs62286643	chr3:158351094-158351095	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
16	rs539412768	chr3:158351103-158351104	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs558092746	chr3:158351111-158351112	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs181574429	chr3:158351112-158351113	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs367728977	chr3:158351118-158351119	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs534025534	chr3:158351122-158351123	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs533810783	chr3:158351123-158351124	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
22	rs186836233	chr3:158351144-158351145	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
23	rs574909568	chr3:158351168-158351169	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
24	rs62286644	chr3:158351211-158351212	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
25	rs200378663	chr3:158351233-158351234	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
26	rs557395408	chr3:158351262-158351263	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
27	rs183372331	chr3:158351263-158351264	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
28	rs545754109	chr3:158351268-158351269	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
29	rs12491658	chr3:158351269-158351270	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
30	rs542287145	chr3:158351283-158351284	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
31	rs573200204	chr3:158351312-158351313	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
32	rs540864049	chr3:158351317-158351318	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
33	rs556367880	chr3:158351319-158351320	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
34	rs6797631	chr3:158351384-158351385	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	mRNA abundance
35	rs375968007	chr3:158351454-158351455	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
36	rs536753273	chr3:158351461-158351462	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
37	rs562569988	chr3:158351466-158351467	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
38	rs62286645	chr3:158351500-158351501	Weak transcription	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
39	rs370671218	chr3:158351503-158351504	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
40	rs116797051	chr3:158351569-158351570	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
41	rs372938576	chr3:158351607-158351608	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
42	rs141946865	chr3:158351613-158351614	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
43	rs144232403	chr3:158351640-158351641	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
44	rs151325691	chr3:158351651-158351652	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
45	rs573294132	chr3:158351666-158351667	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
46	rs567368594	chr3:158351683-158351684	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
47	rs187909376	chr3:158351694-158351695	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
48	rs191181711	chr3:158351720-158351721	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
49	rs565418814	chr3:158351723-158351724	Weak transcription	n/a	n/a	Overlapped CNVs	n/a
50	rs140643430	chr3:158351737-158351738	Weak transcription	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:59)

Disease	PMID	Source
Basal cell lymphoma	17053054	CNVD
Esophageal cancer	21851588	CNVD
Uveal melanoma	21693616	CNVD
Glioblastoma multiforme	21080181	CNVD
Retinoblastoma	21504564	CNVD
Medulloblastoma	21979893	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Lung cancer	18438408	CNVD
Squamous cell cancer	20885788	CNVD
Melanoma	18172304	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Breast cancer	22032731	CNVD
Breast cancer	16461572	CNVD
Neuroblastoma	17533364	CNVD
Cervical Cancer	21857958	CNVD
Melanoma	21693616	CNVD
Lung cancer	21426551	CNVD
Cancer	21637783	CNVD
Cervical cancer	21063398	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Liposarcoma	21253554	CNVD
Oral cancer	21386901	CNVD
Renal cell carcinoma	19461508	CNVD
Cancer	22065749	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Basal cell lymphoma	21115979	CNVD
head and neck squamous cell carcinoma	17671120	CNVD
Hepatocellular carcinoma	16750200	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Myelodysplastic syndrome	21251322	CNVD
small cell lung cancer	20016488	CNVD
Acute lymphoblastic leukemia	21339820	CNVD
Basal cell lymphoma	17170743	CNVD
Breast cancer	16608533	CNVD
Myofibroblastic sarcoma	19369631	CNVD
Hodgkin''s lymphoma	17606441	CNVD
Acute myeloid leukemia	20729466	CNVD
Non-small cell lung cancer	19010865	CNVD
abnormal development	18461090	CNVD
Prostate cancer	18632612	CNVD
Ovarian clear cell carcinoma	21343371	CNVD
Colorectal cancer	16272173	CNVD
Prostate cancer	16547154	CNVD
Breast cancer	21364760	CNVD
Gastrointestinal stromal cancer	20818650	CNVD
Cancer	20164919	CNVD
Ovarian cancer	21781307	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Breast cancer	22522925	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:23 , 50 per page) page: 1

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr3:158349000-158351800	Weak transcription	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
2	chr3:158349400-158351400	Enhancers	H9 Derived Neuron Cultured Cells	ES cell derived
3	chr3:158350200-158351800	Weak transcription	HUES48 Cell Line	embryonic stem cell
4	chr3:158350200-158352000	Weak transcription	H1 Cell Line	embryonic stem cell
5	chr3:158350400-158352000	Weak transcription	HUES6 Cell Line	embryonic stem cell
6	chr3:158350600-158351800	Weak transcription	ES-I3 Cell Line	embryonic stem cell
7	chr3:158350600-158352000	Weak transcription	HUES64 Cell Line	embryonic stem cell
8	chr3:158350600-158352000	Weak transcription	iPS-15b Cell Line	embryonic stem cell
9	chr3:158350600-158352200	Weak transcription	H9 Cell Line	embryonic stem cell
10	chr3:158351800-158352000	Enhancers	ES-I3 Cell Line	embryonic stem cell
11	chr3:158351800-158352400	ZNF genes & repeats	hESC Derived CD184+ Endoderm Cultured Cells	ES cell derived
12	chr3:158351800-158352400	ZNF genes & repeats	HUES48 Cell Line	embryonic stem cell
13	chr3:158352000-158352200	Flanking Active TSS	ES-I3 Cell Line	embryonic stem cell
14	chr3:158352000-158352200	Flanking Active TSS	HUES6 Cell Line	embryonic stem cell
15	chr3:158352000-158352200	Flanking Active TSS	iPS-15b Cell Line	embryonic stem cell
16	chr3:158352000-158352200	Flanking Bivalent TSS/Enh	iPS-18 Cell Line	embryonic stem cell
17	chr3:158352000-158352200	ZNF genes & repeats	iPS-20b Cell Line	embryonic stem cell
18	chr3:158352000-158352400	Flanking Active TSS	H1 Cell Line	embryonic stem cell
19	chr3:158352000-158352400	Enhancers	H1 BMP4 Derived Mesendoderm Cultured Cells	ES cell derived
20	chr3:158352000-158352400	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
21	chr3:158352000-158352400	Enhancers	Fetal Brain Female	brain
22	chr3:158352000-158352600	Active TSS	Foreskin Fibroblast Primary Cells skin01	Skin
23	chr3:158352000-158353000	Active TSS	HUES64 Cell Line	embryonic stem cell

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links